BUPRENORPHINE - DEMONSTRATION OF PHYSICAL-DEPENDENCE LIABILITY

被引：65

作者：

DUM, J ^{[1
]}

BLASIG, J ^{[1
]}

HERZ, A ^{[1
]}

机构：

[1] MAX PLANCK INST PSYCHIAT, DEPT NEUROPHARMACOL, KRAEPELINSTR 2, D-8000 MUNICH 40, GERMANY

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1981年 / 70卷 / 03期

关键词：

D O I：

10.1016/0014-2999(81)90163-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：293 / 300

页数：8

共 14 条

[1]

BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19

[2]

BRASE DA, 1976, J PHARMACOL EXP THER, V197, P317

[3] AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].

COWAN, A ;

LEWIS, JW ;

MACFARLANE, IR .

BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545

[4]

COWAN A, 1974, ADV BIOCHEM PSYCHOPH, V8, P427

[5] INVIVO OPIATE BINDING UNCHANGED IN TOLERANT-DEPENDENT MICE [J].

DUM, J ;

MEYER, G ;

HOLLT, V ;

HERZ, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 58 (04) :453-460

[6]

Gibson R D, 1970, J Pharm Sci, V59, P426, DOI 10.1002/jps.2600590338

[7]

HOFFMEISTER F, 1972, SCHMERZ GRUNDLAGEN P, P290

[8] MIXED AGONIST-ANTAGONIST OPIATES AND PHYSICAL-DEPENDENCE [J].

JACOB, JJC ;

MICHAUD, GM ;

TREMBLAY, EC .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 :S291-S296

[9]

JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501

[10]

MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517

← 1 2 →